OpenAlex
PricingAboutJobs
Log inGet started
Work

Characteristics of Patients Losing Vision after 2 Years of Monthly Dosing in the Phase III Ranibizumab Clinical Trials

HTML

Year: 2010
Type: article
Source: Ophthalmology
DOI: 10.1016/j.ophtha.2010.07.011
Authors: Philip J. Rosenfeld, Howard Shapiro, Lisa Tuomi, Mary Webster, Julee Elledge, Barbara Blodi
Institutions: University of Miami, University of Miami Health System, Genentech, University of Wisconsin–Madison
Language: English

Topic: Retinal Diseases and Treatments
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Keywords: ranibizumab, neovascular age-related macular degeneration, visual acuity loss, anti-VEGF therapy, choroidal neovascularization, retinal pigment epithelium abnormalities, geographic atrophy, lesion area, atrophic scars, MARINA trial, ANCHOR trial, treatment safety, fibrosis, hemorrhage, leakage
SDG: Good health and well-being

Open Access status: closed

Funder: Genentech
OpenAlex ID: W2009150210
FWCI: 20.53
Cites: 22
Cited by: 271
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms